Abstract
Myopathies and muscular dystrophies are disease inherent to muscles and have the common feature of muscle weakness. Multiple sleep disorders are associated with them. Sleep disordered breathing disorder (SRBD) is the most common sleep disorder in both myopathies and muscular dystrophies. Various different factors contributed to the development of SRBD that include diaphragmatic involvement, coexisting cardiac abnormalities, reduction in lung volumes and capacities, and airway obstruction. Other sleep disorders in these conditions include insomnia, restless legs syndrome, hypersomnolence, and parasomnias.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fermin AM, Afzal U, Culebras A. Sleep in neuromuscular diseases. Sleep Med Clin. 2016;11(1):53–64. https://doi.org/10.1016/j.jsmc.2015.10.005.Epub2016Jan9.
Peppard PE, Young T, Hla KM. Increased prevalence of sleep-disorderd breathing in adults. Am J Epidemiol. 2013;177(9):1006–14.
Arens R, Muzumdar H. Sleep, Sleep disordered breathing, and nocturnal hypoventilation in children with Neuromuscular diseases. Pediatr Respir Rev. 2010;11(1):24.
Phillips MF, Smith PE, Carroll N, Calverley PM. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 1999;160(1):198–202.
Aboussouan LS. Sleep-disordered breathing in neuromuscular disease. Am J Respir Crit Care Med. 2015;191(9):979–89.
Hudgel DW, Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol. 1984;57:1319–22.
Ibanez J, Raurich JM. Normal values of functional residual capacity in the sitting and supine positions. Intensive Care Med. 1982;8:173–7.
Appleberg J, Nordahl G, Janson C. Lung volume and its correlation to nocturnal apnoea and desaturation. Respir Med. 2000;94:233–9.
Van de Graff WB. Thoracic influence on upper airway patency. J Appl Physiol (1985). 1988;65:2124–31.
White JE, Drinnan MJ, Smithson AJ, Griffiths CJ, Gibson GJ. Respiratory muscle activity and oxygenation during sleep in patients with muscular weakness. Eur Respir J. 1989;2:26–30.
Smith PE, Edwards RH, Claverly PM. Mechanisms of sleep-disordered breathing in chronic neuromuscular disease: implications for management. Q J Med. 1991;81:961–73.
McCool FD, Tzelepis GE. Dysfunction of the diaphragm. N Engl J Med. 2012;366:932–42.
Shahrizaila N, Kinnear WJM, Wills AJ. Respiratory involvement in inherited primary muscle conditions. J Neurol Neurosurg Psychiatry. 2006;77(10):1108–15.
Ferrerio A, Quijano-Roy S, Piche C. Mutations of the Selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71(4):739–49. https://doi.org/10.1086/342719.
Mellies U, Ragette R, Schwake C. Sleep disordered breathing and respiratory failure in acid maltase deficiency. Neurology. 2001;57(7):1290–5.
Teixeira A, Cherin P, Similowski T. Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord. 2005;15(1):32–9. https://doi.org/10.1016/j.nmd.2004.09.006.
Latronico N, Bolton C. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–41. https://doi.org/10.1016/S1474-4422(11)70178-8.
Madej-Pilarczyk A, Kochanski A. Emery-Dreifuss muscular dystrophy: the most recognizable laminopathy. Folia Neuopathol. 2016;54(1):1–8.
Sveen M-L, Thune JJ, Keber L. Cardiac involvement in patients with Limb-Girdle Muscular Dystrophy Type 2 and Becker muscular dystrophy. Arch Neurol. 2008;65(9):1196–201. https://doi.org/10.1001/arch-neur.65.9.1196.
van der Kooi AJ, Van Meegen M, Bolhuis PA. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Genet. 1997;60:891–5.
Perloff JK, Stevenson WG, Weiss J. Cardiac involvement in myotonic muscular dystrophy: a prospective study of 25 patients. Am J Cardiol. 1984;54(8):1074–81. https://doi.org/10.1016/S0002-9149(84)80147-2.
Zhang LH, Fang LG, Cheng ZW, Fang Q. Cardiac manifestations of patients with mitochondrial disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37(10):892–5.
Muller-Hocker J, Schafer S, Mendel B, Lochmuller H, Pongratz D. Nemaline cardiomyopathy in a young adult: an ultraimmunohistochemical study and review of literature. Ultrastruct Pathol. 2000;24(6):407–16.
Banwell BL, Becker LE, Jay V, et al. Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol. 1999;14(2):83–7.
Lanfranchi PA, Braghiroli A, Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:1435–40.
Muller C, Jones H, O’Grady G, Suzrez A, Heller J, Kishnani P. Language and speech function in children with infantile Pompe disease. J Pediatr Neurol. 2009;7:147–56.
Renard D, Humbertclaude V, Labauge P. Macroglossia in adult Duchenne muscular dystrophy. Acta Neurol Belg. 2010;110:288.
Khan Y, Heckmatt JZ. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax. 1994;49:157–61.
Suresh S, Wales P, Cooper DG. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in pediatricpopulation. J Paediatr Child Health. 2005;41:500–3.
Leonardis L, Blague R, Dolenc Groselj L. Sleep and breathing disorders in myotonic dystrophy type 2. Acta Neurol Scand. 2015;132:42–8.
Bianchi MLE, Losurdo A, Silvestri G. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2. Sleep Breath. 2014;18:579–89. https://doi.org/10.1007/s11325-013-0921-5.
Beetar JT, Guilmette TJ, Sparadeo FR. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch Phys Med Rehabil. 1996;77(12):1298–302.
Hoffman AJ, Given BA, Von Eye A. Relationships among pain, fatigue, insomnia and gender in persons with lung cancer. Oncol Nurs Forum. 2007;34(4):785–92.
Jennum P, Drewes AM, Andreasen A, Nielsen KD. Sleep and other symptoms in primary fibromyalgia and in healthy controls. J Rheumatol. 1993;20(10):1756–9.
Power JD, Perrucio AV, Badley EM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum. 2005;53(6):911–9.
Della Marca G, Frusciante R, Vollono C, Ricci E. Pain and the alpha-sleep anomaly: a mechanism of sleep disruption in fascioscapulohumeral muscular dystrophy. Pain Med. 2013;14(4):487–97. https://doi.org/10.1111/pme.12054.
Bushby KM, Pollitt C, Johnson MA, Chinnery PF. Muscle pain as a prominent feature of FSHD: four illustrative case reports. Neuromuscul Disord. 1998;8(8):574–9.
Vianello A, Bevilacqua M, Vincenti E. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne’s muscular dystrophy. Chest. 1994;105(2):445–8.
Mendell JR, Moxley RT, Florence J. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. N Engl J Med. 1989;320(24):1592–7.
Lam EM, Shepard PW, Milone M. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2013;81(2):157–64. https://doi.org/10.1212/WNL.0b013e31829a340f.
Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med. 2009;266(5):419–31. https://doi.org/10.1111/j.1365-2796.2009.02159.
Salas RE, Gamaldo CE, Allen RP. Update in restless legs syndrome. Curr Opin Neurol. 2010;23(4):401–6. https://doi.org/10.1097/WCO.0b013e32833bcdd8.
Akamine RT, Grossklauss LF, Tufik S. Restless leg syndrome exacerbated by amytriptiline in a patient with Duchenne muscular dystrophy. Sleep Sci. 2014;7(3):178–80. https://doi.org/10.1016/j.slsci.2014.09.010. Epub 2014 Sep 27
Dauvilliers YA, Laberge L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep Med Rev. 2012;16(6):539–45. https://doi.org/10.1016/j.smrv.2012.01.001. Epub 2012 Mar 31
Yu H, Laberge L, Dauvilliers Y. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep. 2011;34(2):165–70.
Schneider-Gold C, Bellenberg B, Lukas C. Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness. PLoS One. 2015;10(6):e0130352.
Romigi A, Albanese M, Massa R. Sleep-wake cycle and daytime sleepiness in the myotonic dystrophies. J Neurodegener Dis. 2013;2013:692026.
Chokroverty S, Bhat S, Rosen D, Farheen A. REM behavior disorder in myotonic dystrophy type 2. Neurology. 2012;78(24):2004. https://doi.org/10.1212/WNL.0b013e318259e28c.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Joseph, V., Devasahayam, J., Goyal, M. (2018). Sleep Issues in Myopathic Disorders and Muscular Dystrophies. In: Govindarajan, R., Bollu, P. (eds) Sleep Issues in Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-73068-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-73068-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73067-7
Online ISBN: 978-3-319-73068-4
eBook Packages: MedicineMedicine (R0)